AU3669595A - Pharmaceutical composition for oral administration of flavonoids - Google Patents

Pharmaceutical composition for oral administration of flavonoids

Info

Publication number
AU3669595A
AU3669595A AU36695/95A AU3669595A AU3669595A AU 3669595 A AU3669595 A AU 3669595A AU 36695/95 A AU36695/95 A AU 36695/95A AU 3669595 A AU3669595 A AU 3669595A AU 3669595 A AU3669595 A AU 3669595A
Authority
AU
Australia
Prior art keywords
flavonoids
pharmaceutical composition
oral administration
micronised
pref
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU36695/95A
Other versions
AU706027B2 (en
Inventor
Alain Cuine
Bruno Huet De Barochez
Noel Piot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of AU3669595A publication Critical patent/AU3669595A/en
Application granted granted Critical
Publication of AU706027B2 publication Critical patent/AU706027B2/en
Assigned to LES LABORATOIRES SERVIER reassignment LES LABORATOIRES SERVIER Alteration of Name(s) in Register under S187 Assignors: ADIR ET COMPAGNIE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Oral compsns. contain a rutaceous flavonoid, partic. micronised diosmin (I), as an effervescent granulate in the form of tablets or sachets. The compsn. pref. comprises 0.1-5 g (I) which is pref. micronised to a particle size of 0.1-10 mu m. The effervescent formulation is achieved by use of a carboxylic acid and one or more carbonates. Other ingredients include sweeteners, flavourings and carriers. The small amt. of water present in (I) is used to start a single phase granulation process.
AU36695/95A 1994-11-08 1995-11-06 Pharmaceutical composition for oral administration of flavonoids Ceased AU706027B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9413336A FR2726469B1 (en) 1994-11-08 1994-11-08 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS
FR9413336 1994-11-08

Publications (2)

Publication Number Publication Date
AU3669595A true AU3669595A (en) 1996-05-16
AU706027B2 AU706027B2 (en) 1999-06-10

Family

ID=9468588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36695/95A Ceased AU706027B2 (en) 1994-11-08 1995-11-06 Pharmaceutical composition for oral administration of flavonoids

Country Status (18)

Country Link
EP (1) EP0711560B1 (en)
JP (1) JP3022952B2 (en)
KR (1) KR960016901A (en)
CN (1) CN1131538A (en)
AT (1) ATE202480T1 (en)
AU (1) AU706027B2 (en)
CA (1) CA2162299C (en)
CY (1) CY2265B1 (en)
DE (1) DE69521477T2 (en)
DK (1) DK0711560T3 (en)
ES (1) ES2160145T3 (en)
FI (1) FI117123B (en)
FR (1) FR2726469B1 (en)
GR (1) GR3036244T3 (en)
NO (1) NO311402B1 (en)
NZ (1) NZ280418A (en)
PT (1) PT711560E (en)
ZA (1) ZA959473B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10639294B2 (en) 2018-10-02 2020-05-05 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
US11304968B2 (en) 2018-11-16 2022-04-19 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011151A3 (en) * 1997-05-13 1999-05-04 Jose Remacle Use of a pharmaceutical composition for treating and / or preventing ischemia.
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP4273277B2 (en) * 1999-06-30 2009-06-03 大塚製薬株式会社 Oligosaccharide supplement composition
JP2001158796A (en) * 1999-11-30 2001-06-12 Toyo Seito Kk Method for producing alpha-glucosyldiosmin and flavonoid composition
FR2845597B1 (en) * 2002-10-11 2005-03-11 Innothera Lab Sa DRY ORAL FORMULATION CONTAINING DIOSMINE AS A PHARMACEUTICAL FORM OF A TABLET TO BE CROQUERED
EP1556021B1 (en) * 2002-10-24 2007-12-19 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
AT501682A1 (en) 2005-01-14 2006-10-15 Hermine Dr Engl METHOD FOR PRODUCING AN ACTIVE SUBSTANCE MIXTURE
ITMI20050517A1 (en) 2005-03-30 2006-09-30 Therapicon Srl PHARMACEUTICAL COMPOSITION OF A TYPICAL MICROCRYSTALLINE FRACTION OF FLAVONOIDS
ITMI20051942A1 (en) * 2005-10-14 2007-04-15 S I I T S R L Servizio Interna GALATTOGENIC COMPOSITIONS BASED ON SILIMARINE
US20070122363A1 (en) * 2005-11-26 2007-05-31 Giniger Martin S Corporeal delivery of carotenoids
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.
MX2012001568A (en) * 2009-08-10 2012-04-02 Stokely Van Camp Inc Method for suspending a flavonoid in a beverage.
MD3987C2 (en) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MD3986C2 (en) * 2009-09-23 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
MD4231C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
MD4232C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
FR2999934B1 (en) 2012-12-21 2015-02-20 Servier Lab PHARMACEUTICAL COMPOSITION IN THE FORM OF AN ORAL SUSPENSION COMPRISING A FLAVONOIC FRACTION AND XANTHAN GUM
CA2961445C (en) 2014-09-17 2019-03-26 Babu Padmanabhan Effervescent composition and method of making it
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
FR3083980B1 (en) 2018-07-20 2021-04-16 Servier Lab PHARMACEUTICAL COMPOSITION IN THE FORM OF A CHEWABLE TABLET OF DIOSMINE OR A FLAVONOIC FRACTION
WO2021123341A1 (en) 2019-12-20 2021-06-24 Krka, D.D., Novo Mesto Composition comprising diosmin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6967M (en) * 1968-01-22 1969-05-19
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
RO81345B1 (en) * 1980-07-28 1983-02-28 Nicolae Oita Medicament for peripheral cardiovascular insufficiency
AU575930B2 (en) * 1984-03-01 1988-08-11 Hamilton Laboratories Pty. Ltd. Treatment of high protein oedemas in animals
FR2577437A1 (en) * 1985-02-21 1986-08-22 Corbiere Jerome New process for dissolving chemical compounds and aqueous preparations thus obtained
IT1201149B (en) * 1987-01-14 1989-01-27 Indena Spa BIOFLAVONOID COMPLEXES WITH PHOSPHOLIPIDS, THEIR PREPARATION, USE AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS
FR2634376B1 (en) * 1988-07-21 1992-04-17 Farmalyoc NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
FR2661610B1 (en) * 1990-05-02 1994-09-30 Rhone Poulenc Sante NOVEL LYOPHILIZED FORM OF DIOSMINE AND ITS PREPARATION.
FR2661830B1 (en) * 1990-05-11 1992-09-04 Corbiere Jerome NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON FLAVONOSIDE.
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10639294B2 (en) 2018-10-02 2020-05-05 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
US11304968B2 (en) 2018-11-16 2022-04-19 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide

Also Published As

Publication number Publication date
CA2162299A1 (en) 1996-05-09
JPH08208469A (en) 1996-08-13
DE69521477D1 (en) 2001-08-02
CA2162299C (en) 2008-09-09
KR960016901A (en) 1996-06-17
FI955310A (en) 1996-05-09
AU706027B2 (en) 1999-06-10
EP0711560B1 (en) 2001-06-27
GR3036244T3 (en) 2001-10-31
NO311402B1 (en) 2001-11-26
CY2265B1 (en) 2003-07-04
ZA959473B (en) 1996-05-15
EP0711560A1 (en) 1996-05-15
FI117123B (en) 2006-06-30
NO954455L (en) 1996-05-09
JP3022952B2 (en) 2000-03-21
FR2726469A1 (en) 1996-05-10
CN1131538A (en) 1996-09-25
ES2160145T3 (en) 2001-11-01
DE69521477T2 (en) 2002-04-18
NZ280418A (en) 1997-03-24
PT711560E (en) 2001-10-30
FR2726469B1 (en) 1996-12-13
ATE202480T1 (en) 2001-07-15
NO954455D0 (en) 1995-11-07
DK0711560T3 (en) 2001-09-03
FI955310A0 (en) 1995-11-06

Similar Documents

Publication Publication Date Title
AU3669595A (en) Pharmaceutical composition for oral administration of flavonoids
AU613517B2 (en) Morphine-containing composition
HUT49629A (en) Process for producing peptide-boronic acid derivatives inhibiting trypsin-like proteases and pharmaceutical compositions comprising such compounds as active ingredient
IL107221A0 (en) Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation
CA2103793A1 (en) Solvent system to be enclosed in capsules
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
AU679200B2 (en) Effervescent pharmaceutical composition containing ibuprofenand method for preparing same
GB8730011D0 (en) Pharmaceutical compositions
AU4846690A (en) Polyunsaturated fatty acid derivatives, pharmaceutical compositions containing the same, method for the preparation thereof, and their use as medicament
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
HUT61024A (en) Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient
CA2063689A1 (en) Ibuprofen lysinate pharmaceutical formulation
CA2136071A1 (en) 2-arylpropionic acid compositions and process for preparing the same
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
HUT71555A (en) New pharmaceutical formulations of spiramycine and process to prepare them
CA2191855A1 (en) Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
CA2173158A1 (en) Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: LES LABORATOIRES SERVIER

Free format text: FORMER OWNER WAS: ADIR ET COMPAGNIE